南方医药保健灵活配置混合C(014933)利润分配表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 收入 |
-379,030,298.57 |
-281,887,448.28 |
-278,938,714.97 |
-149,892,261.74 |
| 利息合计 |
2,032,589.70 |
1,245,979.86 |
776,968.22 |
389,811.53 |
| 其中：存款利息收入 |
523,523.38 |
249,361.82 |
675,928.20 |
389,811.53 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
1,509,066.32 |
996,618.04 |
101,040.02 |
- |
| 投资收益合计 |
-287,718,185.30 |
-228,837,730.29 |
-428,889,141.29 |
-281,725,069.08 |
| 其中：股票投资收益 |
-323,240,295.67 |
-253,669,554.40 |
-458,013,767.01 |
-303,013,507.42 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
3,403,850.30 |
1,612,306.56 |
3,026,133.04 |
799,007.95 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
32,118,260.07 |
23,219,517.55 |
26,098,492.68 |
20,489,430.39 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-94,248,239.31 |
-54,536,680.60 |
148,149,302.37 |
130,871,776.65 |
| 其他收入 |
903,536.34 |
240,982.75 |
1,024,155.73 |
571,219.16 |
| 费用 |
39,411,713.28 |
19,028,646.42 |
46,424,335.92 |
26,423,853.43 |
| 管理人报酬 |
33,462,339.93 |
16,148,961.07 |
39,434,275.74 |
22,468,917.79 |
| 基金托管费 |
5,577,056.67 |
2,691,493.59 |
6,572,379.30 |
3,744,819.66 |
| 销售服务费 |
115,618.53 |
58,129.28 |
163,288.78 |
83,552.13 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
256,697.76 |
130,062.09 |
254,390.69 |
126,563.18 |
| 利润总额 |
-418,442,011.85 |
-300,916,094.70 |
-325,363,050.89 |
-176,316,115.17 |
微信公众号
证券之星APP
基本资料
